Intervention not reported
Sclerotherapy · people with liver cirrhosis and previous oesophageal variceal bleeding
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
No active intervention(1 RCT; 40 participants) · people with liver cirrhosis and previous oesophageal variceal bleeding
The intervention may leads to lower no active intervention(1 RCT; 40 participants) (low certainty).
1 finding from 1 review
OR 0.22 [0.05, 0.86]
Studies not reported
Low
Intervention not reported
TIPS(No direct RCT) · people with liver cirrhosis and previous oesophageal variceal bleeding
The intervention may leads to lower TIPS(No direct RCT) (low certainty).
1 finding from 1 review
OR 0.02 [0, 0.17]
Studies not reported
Low
Intervention not reported
Beta‐blockers plus Sclerotherapy(2 RCTs; 128 participants) · people with liver cirrhosis and previous oesophageal variceal bleeding
The intervention showed no clear difference in beta‐blockers plus Sclerotherapy(2 RCTs; 128 participants) (low certainty).
1 finding from 1 review
Intervention not reported
TIPS(1 RCT; 63 participants) · people with liver cirrhosis and previous oesophageal variceal bleeding
The intervention showed no clear difference in TIPS(1 RCT; 63 participants) (low certainty).
1 finding from 1 review
Intervention not reported
Portocaval shunt(1 RCT; 45 participants) · people with liver cirrhosis and previous oesophageal variceal bleeding
The intervention showed no clear difference in portocaval shunt(1 RCT; 45 participants) (low certainty).
1 finding from 1 review
Intervention not reported
Beta‐blockers plus Sclerotherapy(1 RCT; 40 participants) · people with liver cirrhosis and previous oesophageal variceal bleeding
It is very uncertain whether the intervention changes beta‐blockers plus Sclerotherapy(1 RCT; 40 participants) (very low certainty).
1 finding from 1 review
HR 1.26 [0.17, 10.1]
Studies not reported
Very low
Intervention not reported
TIPS(1 RCT; 80 participants) · people with liver cirrhosis and previous oesophageal variceal bleeding
It is very uncertain whether the intervention changes TIPS(1 RCT; 80 participants) (very low certainty).
1 finding from 1 review
HR 1.52 [0.39, 6.6]
Studies not reported
Very low
Intervention not reported
Beta‐blockers(1 RCT; 28 participants) · people with liver cirrhosis and previous oesophageal variceal bleeding
It is very uncertain whether the intervention changes beta‐blockers(1 RCT; 28 participants) (very low certainty).
1 finding from 1 review
HR 0.46 [0, 43.25]
Studies not reported
Very low
Intervention not reported
Beta‐blockers(9 RCTs; 493 participants) · people with liver cirrhosis and previous oesophageal variceal bleeding
The intervention showed no clear difference in beta‐blockers(9 RCTs; 493 participants) (low certainty).
1 finding from 1 review
HR 0.88 [0.66, 1.18]
Studies not reported
Low
Intervention not reported
No active intervention(No direct RCT) · people with liver cirrhosis and previous oesophageal variceal bleeding
It is very uncertain whether the intervention changes no active intervention(No direct RCT) (very low certainty).
1 finding from 1 review
HR 1.19 [0, 1726.76]
Studies not reported
Very low
Intervention not reported
Beta‐blockers(6 RCTs; 420 participants) · people with liver cirrhosis and previous oesophageal variceal bleeding
The intervention probably leads to higher beta‐blockers(6 RCTs; 420 participants) (moderate certainty).
1 finding from 1 review
HR 1.62 [1.14, 2.38]
Studies not reported
Moderate
Intervention not reported
Beta‐blockers plus sclerotherapy(4 RCTs; 231 participants) · people with liver cirrhosis and previous oesophageal variceal bleeding
The intervention probably leads to lower beta‐blockers plus sclerotherapy(4 RCTs; 231 participants) (moderate certainty).
1 finding from 1 review
HR 0.6 [0.37, 0.95]
Studies not reported
Moderate
Intervention not reported
No active intervention(3 RCTs; 296 participants) · people with liver cirrhosis and previous oesophageal variceal bleeding
The intervention probably leads to higher no active intervention(3 RCTs; 296 participants) (moderate certainty).
1 finding from 1 review
HR 1.61 [1.01, 2.86]
Studies not reported
Moderate
Intervention not reported
TIPS(2 RCTs; 109 participants) · people with liver cirrhosis and previous oesophageal variceal bleeding
The intervention probably leads to lower TIPS(2 RCTs; 109 participants) (moderate certainty).
1 finding from 1 review
HR 0.18 [0.08, 0.38]
Studies not reported
Moderate
Intervention not reported
Beta‐blockers plus nitrates(No direct RCT) · people with liver cirrhosis and previous oesophageal variceal bleeding
The intervention showed no clear difference in beta‐blockers plus nitrates(No direct RCT) (low certainty).
1 finding from 1 review
HR 2.13 [0.79, 5.86]
Studies not reported
Low
Intervention not reported
Portocaval shunt(No direct RCT) · people with liver cirrhosis and previous oesophageal variceal bleeding
The intervention probably leads to lower portocaval shunt(No direct RCT) (moderate certainty).
1 finding from 1 review
HR 0.21 [0.05, 0.77]
Studies not reported
Moderate
Intervention not reported
Beta‐blockers(1 RCT; 65 participants) · people with liver cirrhosis and previous oesophageal variceal bleeding
The intervention may leads to higher beta‐blockers(1 RCT; 65 participants) (low certainty).
1 finding from 1 review
Intervention not reported
Beta‐blockers plus Sclerotherapy(8 RCTs; 370 participants) · people with liver cirrhosis and previous oesophageal variceal bleeding
The intervention showed no clear difference in beta‐blockers plus Sclerotherapy(8 RCTs; 370 participants) (low certainty).
1 finding from 1 review
HR 0.69 [0.43, 1.09]
Studies not reported
Low
Intervention not reported
No active intervention(4 RCTs; 412 participants) · people with liver cirrhosis and previous oesophageal variceal bleeding
The intervention showed no clear difference in no active intervention(4 RCTs; 412 participants) (low certainty).
1 finding from 1 review
HR 1.2 [0.83, 1.84]
Studies not reported
Low